MILESTONE PHARMACEUTICALS IN MIST
COM · Common Stock · CUSIP 59935V107
- SectorHealth care
- IndustryPharmaceutical Preparations
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Shares outstanding: 24.5m as of 2019-11-01, from the company's own SEC filing; the percentage can still exceed 100%: lent-out shares are counted by the lender and the buyer, and some reports overlap without saying so. Implied quarter-end price ≈ $16.01.
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| RTW INVESTMENTS, LP 13G · institution no change · filed 2026-05-15 | 9.9% |
| Propel Bio Management, LLC 13G · passive investor new · filed 2025-12-23 | 9.9% |
| Pavaki Capital Management LLC 13G · passive investor new · filed 2026-08-07 | 7.3% |
| Adage Capital Management, L.P. 13G · institution -3.6 pts · filed 2026-05-13 | 6.4% |
Fell to 5% or below in the last year: Trails Edge Capital Partners, LP (4.3%, 2026-03-26)
Insider purchases and sales in Q4 2019
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
None reported in Q4 2019.
Holders, Q4 2019
| Manager | Shares | Change |
|---|---|---|
| RTW INVESTMENTS, LP 2.39% of their portfolio | 4.0m $63.4m | — |
| NOVO HOLDINGS A/S 2.51% of their portfolio | 2.4m $39.0m | — |
| VHCP Management III, LLC 6.57% of their portfolio | 2.1m $33.1m | — |
| PRICE T ROWE ASSOCIATES INC /MD/ 0.00% of their portfolio | 1.3m $20.6m | — |
| Boxer Capital, LLC 1.00% of their portfolio | 1.1m $17.6m | — |
| Tekla Capital Management LLC 0.45% of their portfolio | 746.7k $12.0m | — |
| ADAGE CAPITAL PARTNERS GP, L.L.C. 0.02% of their portfolio | 600.0k $9.6m | — |
| ACUTA CAPITAL PARTNERS, LLC 2.32% of their portfolio | 508.5k $8.1m | — |
| ORBIMED ADVISORS LLC 0.08% of their portfolio | 364.2k $5.8m | — |
| Invesco Ltd. 0.00% of their portfolio | 322.4k $5.2m | — |
| FMR LLC 0.00% of their portfolio | 239.6k $3.8m | — |
| Ghost Tree Capital, LLC 1.02% of their portfolio | 235.0k $3.8m | — |
| Zimmer Partners, LP 0.04% of their portfolio | 160.0k $2.6m | — |
| VHCP Management II, LLC 0.63% of their portfolio | 148.6k $2.4m | — |
| MORGAN STANLEY 0.00% of their portfolio | 46.8k $749.0k | — |
| Prosight Management, LP 0.28% of their portfolio | 38.5k $616.0k | — |
| TD Asset Management Inc 0.00% of their portfolio | 36.3k $581.0k | — |
| Pentwater Capital Management LP 0.02% of their portfolio | 32.0k $512.0k | — |
| MILLENNIUM MANAGEMENT LLC 0.00% of their portfolio | 29.5k $472.0k | — |
| Federation des caisses Desjardins du Quebec 0.01% of their portfolio | 23.0k $368.1k | — |
| OXFORD ASSET MANAGEMENT LLP 0.01% of their portfolio | 19.7k $316.0k | — |
| BARCLAYS PLC 0.00% of their portfolio | 900 $14.0k | — |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 245 $4.0k | — |
| Tower Research Capital LLC (TRC) 0.00% of their portfolio | 142 $2.0k | — |
| Wealthcare Advisory Partners LLC 0.00% of their portfolio | 52 $1.0k | — |